...
首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors
【24h】

7-Acylamino-3H-1,2-benzoxathiepine 2,2-dioxides as new isoform-selective carbonic anhydrase IX and XII inhibitors

机译:7-酰基氨基-3H-1,2-苯并卓卓杂志2,2-二氧化氧化物作为新同种型选择性碳酸酐酶IX和XII抑制剂

获取原文
           

摘要

A series of 3H-1,2-benzoxathiepine 2,2-dioxides incorporating 7-acylamino moieties were obtained by an original procedure starting from 5-nitrosalicylaldehyde, which was treated with propenylsulfonyl chloride followed by Wittig reaction of the bis-olefin intermediate. The new derivatives, belonging to the homosulfocoumarin chemotype, were assayed as inhibitors of the zinc metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1). Four pharmacologically relevant human (h) isoforms were investigated, the cytosolic hCA I and II and the transmembrane, tumour-associated hCA IX and XII. No relevant inhibition of hCA I and II was observed, whereas some of the new derivatives were effective, low nanomolar hCA IX/XII inhibitors, making them of interest for investigations in situations in which the activity of these isoforms is overexpressed, such as hypoxic tumours, arthritis or cerebral ischaemia.
机译:通过从5-硝基水杨醛开始的原始程序获得掺入7-酰基氨基部分的3H-1,2-苯并卓昔偶二氧化物2,2-二氧化氧化物,其用丙烯基磺酰氯处理,然后用双烯烃中间体的Wittig反应处理。属于Homosulfocoumarin趋化型的新衍生物被测定为锌金属酶碳酸酐酶(CA,EC 4.2.1.1)的抑制剂。研究了四种药理学相关的人(H)同种型,细胞溶质HCA I和II和跨膜,肿瘤相关的HCA IX和XII。未观察到HC 8和II的相关抑制,而一些新的衍生物是有效的,低纳米摩尔HCA IX / XII抑制剂,使其感兴趣的是在这些同种型的活性过表达的情况下的情况,例如缺氧肿瘤,关节炎或脑缺血。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号